King Minos II hall
King Minos II hall
Hereditary nephropathies
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
Διαλειμμα - Καφές
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
Breakthrough in Nephrology
N.5A. Changing the status quo in CKD
1. SGLT2 inhibitors: what's new? Dimitrios Vlahakos
2. The place of GLP-1 agonists in clinical practice Petros Kalogeropoulos
3. The place of MRAs in clinical practice Konstantinos Psounis
Lunch
Διαλειμμα - Γεύμα
Δ.3. Νέες και αναδυόμενες θεραπείες στη νεφροπάθεια IgA
Hereditary nephropathies
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
Διαλειμμα - Καφές
Hereditary nephropathies
Haemodialysis
N.2B. Quality of services and patient safety
1. Quality in practice - Diaverum paradigm
2. TBC
3. Policy on quality of services and patient safety in the Dialysis Units of the Greek National Health System
4. EN.I.N. Dialysis Unit Accreditation Program by HASIN
Δ.1.. Παχυσαρκία ως νεφρική νόσος: μηχανισμοί, κίνδυνος και νέες θεραπευτικές δυνατότητες
Close
Approved by:
Participants:
Participants:
